Rimmel London

Manufacturer
Lancaster S.A.M. | Rimmel Inc.
Effective date
2010-10-20
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:29:56

Label at a glance#

ProductRimmel London Moisture Renew Lipgloss - Rose Cocoon (115)
Active ingredientOCTINOXATE, OCTISALATE
Label structure5 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

USE: Helps prevent sunburn.

WARNINGS SECTION

WARNING: Stop use if skin rash occurs.

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Octinoxate 7.5%, Octisalate 2.0%.



INACTIVE INGREDIENT SECTION

COSMETIC INGREDIENTS: POLYBUTENE, HYDROGENATED
POLYISOBUTENE, PARAFFINUM LIQUIDUM/MINERAL OIL/
HUILE MINERALE, ETHYLHEXYL PALMITATE, LANOLIN OIL,
ETHYLENE/PROPYLENE/STYRENE COPOLYMER, POLYETHYLENE,
CALCIUM ALUMINUM BOROSILICATE, SILICA DIMETHYL
SILYLATE, SILICA, SYNTHETIC FLUORPHLOGOPITE,

ISOPROPYLPARABEN,BUTYLENE/ETHYLENE/STYRENE
COPOLYMER, TOCOPHERYL ACETATE, PENTAERYTHRITYL
TETRAISOSTEARATE, BUTYLPARABEN, ISOBUTYLPARABEN,
PARFUM/FRAGRANCE, TRIBEHENIN, CARMINE, LINALOOL, BHT,
ASCORBYL PALMITATE, RETINYL PALMITATE, TIN OXIDE,
HYDROXYCITRONELLAL, SORBITAN ISOSTEARATE, HEXYL

CINNAMAL, BUTYLENE GLYCOL, PALMITIC ACID,
PHENOXYETHANOL, METHYLPARABEN, SODIUM CHONDROITIN
SULFATE, PROPYLPARABEN, CAPRYLYL GLYCOL, ATELOCOLLAGEN,
SODIUM HYALURONATE, HEXYLENE GLYCOL, PALMITOYL
OLIGOPEPTIDE, ETHYLPARABEN. [MAY CONTAIN/PEUT CONTENIR/
: MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES

(CI 77491, CI 77492, CI 77499), DandC RED NO. 7 CALCIUM LAKE
(CI 15850), DandC RED NO. 6 BARIUM LAKE (CI 15850), FDandC
YELLOW NO. 5 ALUMINUM LAKE (CI 19140), DandC RED NO. 33
ALUMINUM LAKE (CI 17200), FDandC BLUE NO. 1 ALUMINUM LAKE
CI 42090), FDandC YELLOW NO. 6 ALUMINUM LAKE (CI 15985),
DandC RED NO. 27 ALUMINUM LAKE (CI 45410)].

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RIMMEL LONDON

SPF 15 SUNSCREEN

MOISTURE RENEW

WITH COLLAGEN AND VITAMINS A, C and E

CREAM LIPGLOSS

0.20 fl oz 6 ml


Principal_Display_PanelPrincipal_Display_Panel


Ingredients_Color_115Ingredients_Color_115


UseUse

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
910c1bd7-67d1-44c7-ad4f-9445f827edccProduct name120230808
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59351-0303-12019-11-13C16284748780-197449f38-c16d-f6ea-e053-dbdaa90aa703Rimmel London Moisture Renew Lipgloss Rose Cocoon (115) SPF 15 Sunscreen

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59351-0303-1Rimmel LondonMoisture Renew Lipgloss - Rose Cocoon (115)6 mL in 1 TUBECREAM63

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59351-0303RIMMEL LONDON MOISTURE RENEW LIPGLOSS - ROSE COCOON (115) (OCTINOXATE, OCTISALATE) CREAM [LANCASTER S.A.M.]3Legacy NDC, 1 package rows20111028_f0733fe5-312a-47e2-9a18-e363b95e1a5c.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD513
OCTISALATEACTIVE INGREDIENT4X49Y0596W3
OCTINOXATEACTIVE MOIETY4Y5P7MUD513
OCTISALATEACTIVE MOIETY4X49Y0596W3
.ALPHA.-HEXYLCINNAMALDEHYDEINACTIVE INGREDIENT7X6O37OK2I3
.ALPHA.-TOCOPHEROL ACETATE, D-INACTIVE INGREDIENTA7E6112E4N3
ALUMINUMINACTIVE INGREDIENTCPD4NFA9033
ASCORBYL PALMITATEINACTIVE INGREDIENTQN83US2B0N3
BARIUMINACTIVE INGREDIENT24GP945V5T3
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K3
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA3
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV83
CALCIUMINACTIVE INGREDIENTSY7Q814VUP3
CAPRYLYL GLYCOLINACTIVE INGREDIENT00YIU5438U3
ETHYLENEINACTIVE INGREDIENT91GW059KN73
ETHYLHEXYL PALMITATEINACTIVE INGREDIENT28659933093
ETHYLPARABENINACTIVE INGREDIENT14255EXE393
HEXYLENE GLYCOLINACTIVE INGREDIENTKEH0A3F75J3
HYALURONATE SODIUMINACTIVE INGREDIENTYSE9PPT4TH3
HYDROXYCITRONELLALINACTIVE INGREDIENT8SQ0VA4YUR3
IRONINACTIVE INGREDIENTE1UOL152H73
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58G3
ISOPROPYLPARABENINACTIVE INGREDIENTA6EOX47QK03
LANOLININACTIVE INGREDIENT7EV65EAW6H3
LINALOOL, (+/-)-INACTIVE INGREDIENTD81QY6I88E3
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T3
MICAINACTIVE INGREDIENTV8A1AW08803
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP3
PALMITIC ACIDINACTIVE INGREDIENT2V16EO95H13
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T3
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU43
SORBITANINACTIVE INGREDIENT6O92ICV9RU3
STANNIC OXIDEINACTIVE INGREDIENTKM7N50LOS63
SULFATE IONINACTIVE INGREDIENT7IS9N8KPMG3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP3
TRIBEHENININACTIVE INGREDIENT8OC9U7TQZ03
VITAMIN A PALMITATEINACTIVE INGREDIENT1D1K0N0VVC3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 38 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59351-030359351-0303-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 37 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 357 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ETHYLPARABENETHYLPARABEN14255EXE39POWDER, FOR SOLUTION / ORAL13 mgExact identifier — unii candidate
4 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, EXTENDED RELEASE / ORAL450 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUSPENSION / ORAL400 mgExact identifier — unii candidate
49 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / ORAL100 mgExact identifier — unii candidate
68 equally ranked IID candidates
LANOLINLANOLIN7EV65EAW6HSHAMPOO / TOPICAL2 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SOLUTION / INTRAMUSCULAR5 mgExact identifier — unii candidate
68 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SOLUTION / ORAL280 mgExact identifier — unii candidate
49 equally ranked IID candidates
SORBITANSORBITAN6O92ICV9RUELIXIR / ORAL0.6 ml/15mlExact identifier — unii candidate
3 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSHAMPOO / TOPICAL0.03 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUPPOSITORY / VAGINALNAExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSPRAY / TOPICAL0.2 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / RESPIRATORY (INHALATION)0.03 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / INTRAMUSCULAR1 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET / ORAL1.8 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPOWDER / ORALNAExact identifier — unii candidate
79 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, COATED / ORAL176 mgExact identifier — unii candidate
49 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, CHEWABLE / ORAL1.28 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHENEMA / RECTAL0.02 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / TOPICAL216 mgExact identifier — unii candidate
79 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY / VAGINALNAExact identifier — unii candidate
40 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8TABLET, EXTENDED RELEASE / ORAL0.01 mgExact identifier — unii candidate
15 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHFILM / BUCCAL0.22 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSUPPOSITORY / VAGINALNAExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INFILTRATION0.35 mgExact identifier — unii candidate
68 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8SOLUTION / ORAL6 mgExact identifier — unii candidate
15 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / VAGINAL8 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHDROPS / NASAL14 mgExact identifier — unii candidate
68 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSOAP / TOPICAL1 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / ORAL346 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, COATED / ORAL0.8 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INTRALESIONAL0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / TOPICAL6 mgExact identifier — unii candidate
49 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSPRAY / TOPICAL0.8 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8DROPS / ORALNAExact identifier — unii candidate
15 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSWAB / TOPICAL0.5 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR3.6 mgExact identifier — unii candidate
79 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS0.8 mgExact identifier — unii candidate
68 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING / ORAL6 mgExact identifier — unii candidate
40 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / RECTAL1808 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPOWDER, FOR SOLUTION / ORAL126 mgExact identifier — unii candidate
79 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE1 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER / ORAL2 mgExact identifier — unii candidate
40 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / TOPICAL420 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAVENOUS95 mgExact identifier — unii candidate
79 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSHAMPOO, SUSPENSION / TOPICAL3 %w/vExact identifier — unii candidate
40 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGUM, CHEWING / BUCCAL5 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / PARENTERAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8LOTION / TOPICAL4 mgExact identifier — unii candidate
15 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4PELLET / ORAL34 mgExact identifier — unii candidate
49 equally ranked IID candidates
IRONIRONE1UOL152H7TABLET, EXTENDED RELEASE / ORAL5 mgExact identifier — unii candidate
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / INTRAMUSCULAR0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPASTE, DENTIFRICE / DENTAL0.4 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCREAM / TOPICAL80 mgExact identifier — unii candidate
40 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d83c1bec-b14e-46a3-a1ad-0bed70ebe183f0733fe5-312a-47e2-9a18-e363b95e1a5c2010-10-20WarningsExact identifier
spl id: d83c1bec-b14e-46a3-a1ad-0bed70ebe183
spl set id: f0733fe5-312a-47e2-9a18-e363b95e1a5c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.